Search Results

Site Search

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D. - Insights

Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma/Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and...

Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics - Insights

Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the...

Visit Mayo Clinic Laboratories at the American Academy of Neurology Annual Meeting 2023 - Insights

Mayo Clinic Laboratories is thrilled to participate in the American Academy of Neurology Annual Meeting 2023.

A comprehensive test menu explores genome for druggable targets to treat gastrointestinal cancers - Insights

Since 1992, cases of colorectal cancer have been on a slow decline, yet 52,550 people died from it in 2023. At Mayo Clinic, a cutting-edge menu of both germline (inherited genetic alterations) and somatic (tumors due to non-inherited...

Mayo Clinic develops and validates new antibody test to diagnose multiple sclerosis - Insights

Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research...

3-D Anatomic Scanning and Modeling: A Technology with Near-Limitless Potential in Pathology Applications - Insights

In the fall of 2017, Shayla Polanchek, a recent recipient of a heart transplant at Mayo Clinic in Rochester, Minnesota, returned to campus to review the specimen of her old heart, the one that had been removed from her chest. She had asked...

Bobbi Pritt, M.D., Advises How to Avoid Bug-Borne Diseases This Summer - Insights

Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and Pathology, recently spoke with the Post-Bulletin about Lyme disease and West...

Robin Patel, M.D., Elected to 2-Year Term on ASM Board of Directors - Insights

Robin Patel, M.D., Chair of the Division of Clinical Microbiology and a Consultant in the Clinical Microbiology and Infectious Diseases Laboratories at Mayo Clinic, has been elected to serve a two-year term on the American Society for...

Robert Jenkins, M.D., Ph.D., Highlighted in "Unlocking the Power of Gene Expression" - Insights

Robert Jenkins, M.D., Ph.D., Consultant in the Division of Laboratory Genetics and Genomics at Mayo Clinic, and other Mayo researchers were highlighted in a recently published video to discuss how the molecular makeup of brain tumors can be...

Vaping-Associated Lung Injury May Be Caused by Toxic Chemical Fumes, Study Finds - Insights

A Mayo Clinic study published in The New England Journal of Medicine finds that lung injuries from vaping most likely are caused by direct toxicity or tissue damage from noxious chemical fumes.